Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints

The Shigella controlled human infection model (CHIM) is valuable for assessing candidate Shigella vaccine efficacy and potentially accelerating regulatory approval. The Shigella CHIM is currently being conducted at 3 sites in the United States using Shigella flexneri 2a strain 2457T and Shigella son...

Descripción completa

Detalles Bibliográficos
Autores principales: MacLennan, Calman A, Riddle, Mark S, Chen, Wilbur H, Talaat, Kawsar R, Jain, Varsha, Bourgeois, A Louis, Frenck, Robert, Kotloff, Karen, Porter, Chad K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901125/
https://www.ncbi.nlm.nih.gov/pubmed/31816065
http://dx.doi.org/10.1093/cid/ciz891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901125/
https://www.ncbi.nlm.nih.gov/pubmed/31816065
http://dx.doi.org/10.1093/cid/ciz891

Ejemplares similares